(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -24.51%42.36M | 119.33%18.1M | 381.51%81.14M | 253.35%27.49M | 1,447.05%93.82M | 960.92%56.12M | -3,371.60%-93.63M | -1,553.70%-28.82M | -466.65%-17.92M | -936.46%-6.97M |
Net income from continuing operations | 108.23%10.01M | 2,126.86%39.13M | -87.91%27.37M | 2,186.72%284.63M | 696.15%51.73M | 240.37%4.81M | -16.45%1.76M | 6,317.97%226.33M | 79.46%-13.64M | -71.62%-8.68M |
Operating gains losses | -38.28%682K | 71.59%-285K | 10.30%889K | 111.81%187K | -287.27%-721K | 183.46%1.11M | 2.15%-1M | 112.11%806K | -102.56%-1.58M | -75.71%385K |
Depreciation and amortization | 4.18%51.27M | 2.94%52.9M | 42,020.35%47.6M | 338,634.21%128.72M | 155,477.78%28M | 820,133.33%49.21M | 856,366.67%51.39M | 1,312.50%113K | -79.79%38K | -89.22%18K |
Asset impairment expenditure | 107.18%271K | --0 | ---7.13M | --12.36M | --7.11M | ---3.77M | --9.02M | --0 | --0 | --0 |
Remuneration paid in stock | ---15K | -144.22%-386K | ---355K | --477K | ---396K | --0 | --873K | --0 | --0 | --0 |
Remuneration paid in stock | 222.66%826K | 321.96%903K | -7.52%529K | 376.63%1.98M | 390.05%936K | 349.12%256K | 296.30%214K | 406.19%572K | 68.70%415K | 63.25%191K |
Other non cashItems | -85.01%1.33M | -185.45%-471K | 102.60%6.21M | -13,394.61%-222.66M | 314.69%7.85M | 3,337.73%8.84M | 95.30%-165K | -99,346.89%-239.19M | -303.96%-1.65M | -16.24%1.89M |
Change In working capital | -66.86%8.18M | 88.73%-6.77M | 134.55%6.03M | -3,497.74%-54.04M | -54.84%-1.2M | 1,684.66%24.69M | -18,437.96%-60.06M | -1,612.03%-17.46M | -3,959.46%-1.5M | -403.92%-775K |
-Change in other working capital | ---- | 88.73%-6.77M | ---- | ---- | ---- | ---- | -18,437.96%-60.06M | ---- | ---- | ---- |
Tax refund paid | -4.02%-30.19M | 30.04%-66.92M | --0 | ---124.17M | --507K | ---29.02M | ---95.65M | --0 | --0 | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -24.51%42.36M | 119.33%18.1M | 381.51%81.14M | 253.35%27.49M | 1,447.05%93.82M | 960.92%56.12M | -3,371.60%-93.63M | -1,553.70%-28.82M | -466.65%-17.92M | -936.46%-6.97M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 6.84%-31.61M | -51.08%-56.03M | -112.02%-28.41M | 896.44%130.35M | -287.41%-35.12M | -5,337.82%-33.93M | -405.25%-37.09M | 35,621.75%236.48M | -216.47%-16.37M | -302,233.33%-9.06M |
Capital expenditure reported | -1.29%-37.2M | -30.84%-50.57M | -691.44%-30.79M | -257,539.53%-110.79M | -350,188.89%-31.53M | -152,904.17%-36.72M | -552,014.29%-38.65M | ---3.89M | ---43K | ---9K |
Net PPE purchase and sale | --108K | ---- | ---- | ---- | ---- | ---- | --101K | ---- | ---- | ---- |
Net business purchase and sale | --0 | --0 | --0 | 6,005.68%238.06M | --0 | --0 | --0 | --238.06M | ---4.03M | --0 |
Net other investing changes | 96.38%5.48M | -473.60%-5.46M | 2.73%2.37M | 125.00%3.07M | 78.58%-3.59M | -3.96%2.79M | 62.81%1.46M | 247.37%2.31M | -4,469.52%-12.29M | -16.81%-16.76M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 6.84%-31.61M | -51.08%-56.03M | -112.02%-28.41M | 896.44%130.35M | -287.41%-35.12M | -5,337.82%-33.93M | -405.25%-37.09M | 35,621.75%236.48M | -216.47%-16.37M | -302,233.33%-9.06M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 72.70%-8.34M | 69.62%-8.67M | -123.60%-9.95M | -475.39%-41.8M | -323.10%-24.84M | -30.56M | -28.55M | 42.16M | 39,867.86%11.14M | 11.14M |
Net issuance payments of debt | 78.62%-6.19M | 67.60%-8.14M | -125.65%-9.01M | -491.52%-42.64M | -317.81%-23.72M | ---28.93M | ---25.11M | --35.13M | 38,992.86%10.89M | --10.89M |
Net common stock issuance | --0 | --0 | --0 | --6.85M | --0 | --0 | --0 | --6.85M | --0 | ---- |
Cash dividends paid | --0 | --0 | ---- | --0 | --0 | --0 | --0 | ---- | --0 | --0 |
Proceeds from stock option exercised by employees | --0 | 415.69%1.32M | 78.74%311K | 305.71%994K | 130.61%565K | --0 | --255K | --174K | --245K | --245K |
Interest paid (cash flow from financing activities) | --0 | --0 | ---- | ---3.14M | ---129K | ---769K | ---2.24M | ---- | --0 | --0 |
Net other financing activities | -151.99%-2.16M | -26.76%-1.85M | ---1.25M | ---3.88M | ---1.56M | ---856K | ---1.46M | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 72.70%-8.34M | 69.62%-8.67M | -123.60%-9.95M | -475.39%-41.8M | -323.10%-24.84M | ---30.56M | ---28.55M | --42.16M | 39,867.86%11.14M | --11.14M |
Net cash flow | ||||||||||
Beginning cash position | 19.84%129.52M | -34.33%176.35M | 664.25%133.87M | -57.10%17.52M | 348.14%100M | 263.74%108.08M | 575.18%268.55M | -57.10%17.52M | 35.44%40.83M | -46.46%22.32M |
Current changes in cash | 128.78%2.41M | 70.74%-46.61M | -82.87%42.78M | 601.13%116.03M | 791.97%33.87M | -17.28%-8.38M | -1,486.80%-159.27M | 23,209.07%249.81M | -313.18%-23.15M | -631.54%-4.89M |
Effect of exchange rate changes | 300.33%1.2M | 81.84%-219K | -124.63%-302K | 304.49%319K | -101.05%-1K | 217.19%300K | -4,724.00%-1.21M | 3,986.67%1.23M | 12.36%-156K | 150.53%95K |
End cash Position | 33.13%133.13M | 19.84%129.52M | -34.33%176.35M | 664.25%133.87M | 664.25%133.87M | 348.14%100M | 263.74%108.08M | 575.18%268.55M | -57.10%17.52M | -57.10%17.52M |
Free cash from | -73.35%5.17M | 75.45%-32.47M | 253.93%50.36M | -363.65%-83.3M | 993.26%62.3M | 396.45%19.39M | -4,791.90%-132.28M | -1,773.65%-32.71M | -461.44%-17.97M | -925.59%-6.97M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data